Interview with Carina Namih
summary
HelixNano describes a concrete device: a Molecular Recorder that writes a cell’s internal events into recoverable sequences so researchers get a time‑series “movie” of molecular changes. It combines genomic and transcriptomic sensors, continuous sampling enabled by falling costs, and cloud‑scale analysis to flag early disease signals and speed drug discovery. Company shows lab data and is building a prototype with Johnson & Johnson, claims partners and grant funding, and discusses data encryption and regulatory needs rather than broad promises.
AI-written summary · about
related talks
24mTechnology’s Next Frontiers
25mHow DNA Origami Disrupts Medicine and Becomes the New Cornerstone of Nano Robotics
06mGenesis Startup Competition Pitch - Drylab AI
10mGenesis Final Round - Drylab AI
19mQuantum-Centric Data Driven R&D with focus on Life Science
20mTranslating a Trillion Pointo Diseases of Data into Therapies
22mReimaging Healthcare
44mNext-Gen Therapies